172 related articles for article (PubMed ID: 34876020)
1. Clinical relevance of glomerular IgM deposition in patients with lupus nephritis.
Wang F; Yu J; Zhang L; Zhang Y; Zhang J; Liu B; Yang X
BMC Immunol; 2021 Dec; 22(1):75. PubMed ID: 34876020
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.
Zhang YM; Gu QH; Huang J; Qu Z; Wang X; Meng LQ; Wang F; Liu G; Cui Z; Zhao MH
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1582-1589. PubMed ID: 27340287
[TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis.
Kim H; Kim T; Kim M; Lee HY; Kim Y; Kang MS; Kim J
Lupus; 2020 Jul; 29(8):862-871. PubMed ID: 32408850
[TBL] [Abstract][Full Text] [Related]
4. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM
Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Impact of Glomerular Immunoglobulin M Deposition in Patients with Type 2 Diabetic Nephropathy.
Tang X; Li H; Li L; Zhang J; Xu H; Li L; Liu F
Am J Med Sci; 2018 Oct; 356(4):365-373. PubMed ID: 30360805
[TBL] [Abstract][Full Text] [Related]
6. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis.
Tan Y; Song D; Wu LH; Yu F; Zhao MH
BMC Nephrol; 2013 Mar; 14():63. PubMed ID: 23510032
[TBL] [Abstract][Full Text] [Related]
7. Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis.
Wang FM; Yu F; Tan Y; Song D; Zhao MH
Rheumatology (Oxford); 2012 Dec; 51(12):2269-77. PubMed ID: 22956549
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.
Kim MK; Maeng YI; Lee SJ; Lee IH; Bae J; Kang YN; Park BT; Park KK
Int J Clin Exp Pathol; 2013; 6(10):2157-67. PubMed ID: 24133594
[TBL] [Abstract][Full Text] [Related]
9. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
Front Immunol; 2020; 11():2073. PubMed ID: 32983156
[No Abstract] [Full Text] [Related]
10. Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients.
Nisihara RM; Magrini F; Mocelin V; Messias-Reason IJ
Hum Immunol; 2013 Aug; 74(8):907-10. PubMed ID: 23639552
[TBL] [Abstract][Full Text] [Related]
11. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
12. Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies.
Aparecida Ferreira V; Aparecida da Silva C; Rodrigues do Carmo Neto J; Rocha LP; Monteiro Dos Santos Martins AL; Antônia Dos Reis M; Machado JR
Ann Diagn Pathol; 2024 Jun; 70():152292. PubMed ID: 38484478
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and renal survival of patients with lupus nephritis with glomerular immunoglobulin G
Jiang X; Lan L; Zhou Q; Wang H; Wang H; Chen J; Han F
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35710146
[TBL] [Abstract][Full Text] [Related]
14. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
Elliott MK; Jarmi T; Ruiz P; Xu Y; Holers VM; Gilkeson GS
Kidney Int; 2004 Jan; 65(1):129-38. PubMed ID: 14675043
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of C1q deposition in serial biopsies for predicating the long-term outcome in patients with proliferative lupus nephritis.
Alsuwaida A; Husain S; Al Ghonaim M; Aloudah N; Ullah A; Kfoury H
Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):305-11. PubMed ID: 26997383
[TBL] [Abstract][Full Text] [Related]
16. Complement Alternative Pathway׳s Activation in Patients With Lupus Nephritis.
Song D; Guo WY; Wang FM; Li YZ; Song Y; Yu F; Zhao MH
Am J Med Sci; 2017 Mar; 353(3):247-257. PubMed ID: 28262211
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q antibodies in lupus nephritis children with glomerular microthrombosis.
Zhang P; Yang X; Fang X; Xu C; Gao C; Xia Z
Nephrology (Carlton); 2023 Sep; 28(9):485-494. PubMed ID: 37485575
[TBL] [Abstract][Full Text] [Related]
18. Renal immunofluorescence and the prediction of renal outcome in patients with proliferative lupus nephritis.
Nossent H; Berden J; Swaak T
Lupus; 2000; 9(7):504-10. PubMed ID: 11035415
[TBL] [Abstract][Full Text] [Related]
19. Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy.
Wu J; Hu Z; Wang Y; Hu D; Yang Q; Li Y; Dai W; Zhu F; Yang J; Wang M; Zhu H; Liu L; He X; Han M; Yao Y; Pei G; Zeng R; Xu G
Histopathology; 2021 May; 78(6):882-895. PubMed ID: 33336446
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
